Identification of gene expression changes in transgenic C-elegans overexpressing human α-synuclein

被引:55
作者
Vartiainen, Suvi
Pehkonen, Petri
Lakso, Merja
Nass, Richard
Wong, Garry
机构
[1] Univ Kuopio, AI Virtanen Inst, Dept Neurobiol, FIN-70211 Kuopio, Finland
[2] Dept Comp Sci, Kuopio 70211, Finland
[3] Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland
[4] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA
[6] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA
基金
芬兰科学院;
关键词
alpha-synuclein; C; elegans; Parkinson's disease; microarray; bioinformatics; clustering;
D O I
10.1016/j.nbd.2005.12.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synuclein containing cellular inclusions are a hallmark of Parkinson Disease, Lewy Body Dementia, and Multiple System Atrophy. A genome wide expression screen was performed in C elegans overexpressing both wild-type and A53T human alpha-synuclein. 433 genes were up- and 67 genes down-regulated by statistical and fold change (> or < 2) criteria. Gene ontology (GO) categories within the regulated gene lists indicated over-representation of development and reproduction, mitochondria, catalytic activity, and histone groups. Seven genes (pdr-1, ubc-7, pas-5, pas-7, pbs-4, RPT2, PSMD9) with function in the ubiquitin-proteasome system and 35 mitochondrial function genes were up-regulated. Nine genes that form histones H1, H2B, and H4 were down-regulated. These results demonstrate the effects of alpha-synuclein on proteasome and mitochondrial complex gene expression and provide further support for the role of these complexes in mediating neurotoxicity. The results also indicate an effect on nuclear protein genes that suggests a potential new avenue for investigation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:477 / 486
页数:10
相关论文
共 66 条
[1]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[2]  
Baba M, 1998, AM J PATHOL, V152, P879
[3]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[4]   THE NACP/SYNUCLEIN GENE - CHROMOSOMAL ASSIGNMENT AND SCREENING FOR ALTERATIONS IN ALZHEIMER-DISEASE [J].
CAMPION, D ;
MARTIN, C ;
HEILIG, R ;
CHARBONNIER, F ;
MOREAU, V ;
FLAMAN, JM ;
PETIT, JL ;
HANNEQUIN, D ;
BRICE, A ;
FREBOURG, T .
GENOMICS, 1995, 26 (02) :254-257
[5]   The biochemistry of Parkinson's disease [J].
Cookson, MR .
ANNUAL REVIEW OF BIOCHEMISTRY, 2005, 74 :29-52
[6]   Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy [J].
Cuervo, AM ;
Stefanis, L ;
Fredenburg, R ;
Lansbury, PT ;
Sulzer, D .
SCIENCE, 2004, 305 (5688) :1292-1295
[7]   Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP [J].
Dauer, W ;
Kholodilov, N ;
Vila, M ;
Trillat, AC ;
Goodchild, R ;
Larsen, KE ;
Staal, R ;
Tieu, K ;
Schmitz, Y ;
Yuan, CA ;
Rocha, M ;
Jackson-Lewis, V ;
Hersch, S ;
Sulzer, D ;
Przedborski, S ;
Burke, R ;
Hen, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14524-14529
[8]   Heat shock protein 70 inhibits α-synuclein fibril formation via preferential binding to prefibrillar species [J].
Dedmon, MM ;
Christodoulou, J ;
Wilson, MR ;
Dobson, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (15) :14733-14740
[9]  
EPSTEIN HF, MODERN BIOL ANAL ORG, P13
[10]   A Drosophila model of Parkinson's disease [J].
Feany, MB ;
Bender, WW .
NATURE, 2000, 404 (6776) :394-398